SCHEMBL10369

SCHEMBL10369

CC(=O)Nc1cc(-c2cccnc2)n(C)n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.56
ADORA2A P29274 1/20 0.52
ADORA1 P30542 1/20 0.52
PIK3CA P42336 2/20 0.47
PIK3CG P48736 2/20 0.47
ALDH1A1 P00352 2/20 0.44
HSD17B10 Q99714 2/20 0.44
HPGD P15428 1/20 0.44
CYP2A6 P11509 2/20 0.43
CYP2A13 Q16696 1/20 0.43
ABL1 P00519 2/20 0.42
PDGFRB P09619 1/20 0.42
BCR P11274 1/20 0.42
PDGFRA P16234 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
MAP4K4 O95819 1/20 0.42
MAPK8 P45983 1/20 0.42
CSNK1A1 P48729 1/20 0.42
CDK7 P50613 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3972385 0.78 ADORA2A (0.37) CYP1A2ADORA2AADORA1PIK3CGALDH1A1
SCHEMBL3972288 0.78 PTGS2 (0.38) CYP1A2ADORA2AADORA1PIK3CGABL1
SCHEMBL10447 0.77 PIK3CG (0.45) PIK3CAPIK3CG
SCHEMBL12279439 0.76 CYP2A6 (0.54) CYP1A2ALDH1A1HSD17B10CYP2A6CYP2A13
SCHEMBL12278777 0.76 NR4A2 (0.49) ALDH1A1HSD17B10CYP2A6CYP2A13ABL1
SCHEMBL10499 0.75 PIK3CG (0.44) PIK3CAPIK3CG
SCHEMBL11005 0.74 ABL1 (0.53) CYP1A2ADORA2AADORA1PIK3CAPIK3CG
SCHEMBL3973580 0.74 ADORA1 (0.37) CYP1A2ADORA2AADORA1HSD17B10ABL1
SCHEMBL10361 0.74 PIK3CG (0.49) PIK3CAPIK3CGCYP2C9
SCHEMBL4508178 0.74 PIP4K2A (0.48) PIK3CAPIK3CGCYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110081316-A1 PYRAZOLE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-04-07 US disclosed
WO-2011041634-A1 PYRAZOLE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110081316-A1 PYRAZOLE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE PIK3CA, PIK3CD, PIK3CG CYP1A2 1605/4885ADORA2A 2470/4885ADORA1 3081/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.